Who owns ASPX - AUSPEX PHARMACEUTICALS INC - COM based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

AUSPEX PHARMACEUTICALS INC - COM (ASPX) Institutional Ownership

Q: What is CUSIP 05211J102?

CUSIP 05211J102 is the security identifier used in SEC filing datasets for ASPX - AUSPEX PHARMACEUTICALS INC - COM.

CUSIP: 05211J102

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2015

Type / Class: Equity / COM
Symbol: ASPX

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 05211J102?
CUSIP 05211J102 identifies ASPX - AUSPEX PHARMACEUTICALS INC - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 05211J102:

Q2 2015 (0 holders) Q1 2015 (138 holders) Q4 2014 (88 holders) Q3 2014 (71 holders) Q2 2014 (61 holders) Q1 2014 (47 holders)

Institutional Holders of AUSPEX PHARMACEUTICALS INC - COM (ASPX) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2015 Q2	0	$0	-$1,893,544,749	$0	$0		0
2015 Q1	19,021,598	$1,907,306,749	+$439,344,390	$1,133,000	$12,835,000	$100.27	138
2014 Q4	14,764,814	$774,849,373	+$139,761,471			$52.48	88
2014 Q3	12,212,358	$313,479,588	+$85,446,137			$25.67	71
2014 Q2	8,902,101	$198,243,527	+$804,655			$22.27	61
2014 Q1	8,817,586	$271,222,000	+$271,222,000			$30.76	47